Ivy P. Altomare

Hematology | Oncology

3100 Tower Blvd Ste 600
Durham, NC 27707

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Utility of automated data transfer for cancer clinical trials and considerations for implementation.

Utility of automated data transfer for cancer clinical trials and considerations for implementation.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Are community oncology practices with or without clinical research programs different? A comparison of patient and practice characteristics.

Are community oncology practices with or without clinical research programs different? A comparison of patient and practice characteristics.

Journal: JNCI cancer spectrum

Published: May 30, 2024

Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023.

Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023.

Journal: JNCI cancer spectrum

Published: May 23, 2024

Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study.

Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study.

Journal: BMJ open

Published: October 17, 2023

Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.

Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.

Journal: JAMA network open

Published: July 21, 2023

Evaluating External Validity of Oncology Biosimilar Safety Studies.

Evaluating External Validity of Oncology Biosimilar Safety Studies.

Journal: JAMA network open

Published: April 06, 2023

Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia.

Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia.

Journal: Clinical pharmacology and therapeutics

Published: May 21, 2021

Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea.

Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 11, 2021

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Journal: Therapeutic advances in hematology

Published: January 20, 2021

Does Cancer Treatment-Related Financial Distress Worsen Over Time?

Does Cancer Treatment-Related Financial Distress Worsen Over Time?

Journal: North Carolina medical journal

Published: January 05, 2021

Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.

Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.

Journal: The oncologist

Published: December 06, 2020

Rapid rise in the cost of targeted cancer therapies for Medicare patients with solid tumors from 2006 to 2015.

Rapid rise in the cost of targeted cancer therapies for Medicare patients with solid tumors from 2006 to 2015.

Journal: Journal of geriatric oncology

Published: July 28, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026